Treatment of familial hyperaldosteronism type I: Only partial suppression of adrenocorticotropin required to correct hypertension

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 9, 2000, Pages 3313-3318

  Stowasser, M ^a   Bachmann, A W ^a   Huggard, P R ^a   Rossetti, T R ^a   Gordon, R D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; CORTICOTROPIN; DEXAMETHASONE; ENALAPRIL; FELODIPINE; GLUCOCORTICOID; HYDRALAZINE; LABETALOL; PREDNISONE; VERAPAMIL;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; FAMILIAL DISEASE; FEMALE; GENE EXPRESSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERALDOSTERONISM; HYPERTENSION; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033694322     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.9.6834     Document Type: Article

References (36)

1. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
2. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin dependent and mediates hypertension in dexamethasone-suppressible aldosteronism
3. A new family with dexamethasone-suppressible hyperaldosteronism: Aldosterone unresponsiveness to angiotensin II
4. Evidence for an unidentified ACTH-induced steroid hormone causing hypertension
5. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism
6. Dexamethasone-suppressible hyperaldosteronism: Adrenal transitional cell hyperplasia?
7. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single pedigree
8. Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism
9. Hybrid gene or hybrid steroids in the detection and screening for familial hyperaldosteronism type I
10. Dexamethasone-suppressible hyperaldosteronism: Studies on overproduction of 18-hydroxycortisol in three affected family members
11. Production of 18-oxo-cortisol in subtypes of primary aldosteronism
12. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension
13. Report of the Second Task Force on Blood Pressure Control in Children-1987
14. Which definition for echocardiographic left ventricular hypertrophy?
15. A radioimmunoassay for plasma aldosterone
16. Application of a radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subjects
17. Dexamethasone-suppressible hypertension
18. Inherited forms of mineralocorticoid hypertension
19. Primary aldosteronism
20. In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild type genes
21. Dexamethasone-suppressible hyperaldosteronism: Patients JS and LS 20 years later
22. Monogenic forms of mineralocorticoid hypertension: Insights into the pathogenesis of 'essential' hypertension?
23. Glucocorticoid-remediable aldosteronism
24. Rapid diagnosis of glucocorticoid suppressible hyperaldosteronism in infants and adolescents
25. Adrenal transitional zone steroids, 18-oxo and 18-hydroxycortisol, useful in the diagnosis of primary aldosteronism, are ACTH dependent
26. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex
27. Glucocorticoid-suppressible hyperaldosteronism: Effects of crossover site and parental origin of chimaeric gene on phenotypic expression
28. Variation of phenotype in patients with glucocorticoid-remediable aldosteronism
29. Familial forms broaden the horizons for primary aldosteronism
30. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I
31. Aldosterone and spironolactone in heart failure
32. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma
33. Adrenal steroids and cardiac fibrosis
34. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system
35. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
36. Evidence for persistent wild type aldosterone synthase gene dysfunction in glucocorticoid-treated familial hyperaldosteronism type 1